The proportion of Bcl-2 positive cases is consistent with reports that two-thirds of non-GCB DLBCL patients will demonstrate high levels of expression [7], as are the mean patient ages at diagnosis because DLBCL is usually diagnosed in the sixth decade of life. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.